Mitochondrial metabolism in primary and metastatic human kidney cancers

Most kidney cancers display evidence of metabolic dysfunction1–4 but how this relates to cancer progression in humans is unknown. We used a multidisciplinary approach to infuse 13C-labeled nutrients during surgical tumour resection in over 70 patients with kidney cancer. Labeling from [U-13C]glucose varies across cancer subtypes, indicating that the kidney environment alone cannot account for all metabolic reprogramming in these tumours. Compared to the adjacent kidney, clear cell renal cell carcinomas (ccRCC) display suppressed labelling of tricarboxylic acid (TCA) cycle intermediates in vivo and in organotypic slices cultured ex vivo, indicating that suppressed labeling is tissue intrinsic. Infusions of [1,2-13C]acetate and [U-13C]glutamine in patients, coupled with respiratory flux of mitochondria isolated from kidney and tumour tissue, reveal primary defects in mitochondrial function in human ccRCC. However, ccRCC metastases unexpectedly have enhanced labeling of TCA cycle intermediates compared to primary ccRCCs, indicating a divergent metabolic program during ccRCC metastasis in patients. In mice, stimulating respiration in ccRCC cells is sufficient to promote metastatic colonization. Altogether, these findings indicate that metabolic properties evolve during human kidney cancer progression, and suggest that mitochondrial respiration may be limiting for ccRCC metastasis but not for ccRCC growth at the site of origin.

[1]  M. V. Vander Heiden,et al.  Slow TCA flux and ATP production in primary solid tumours but not metastases , 2023, Nature.

[2]  Z. Ju,et al.  Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials , 2023, Nature Medicine.

[3]  Quyen N. Do,et al.  In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma , 2022, bioRxiv.

[4]  B. Faubert,et al.  In vivo isotope tracing reveals a requirement for the electron transport chain in glucose and glutamine metabolism by tumors , 2022, Science advances.

[5]  R. Deberardinis,et al.  Comprehensive isotopomer analysis of glutamate and aspartate in small tissue samples , 2022, bioRxiv.

[6]  P. Carmeliet,et al.  PHGDH heterogeneity potentiates cancer cell dissemination and metastasis , 2022, Nature.

[7]  R. Deberardinis,et al.  G6PD deficiency sensitizes metastasizing melanoma cells to oxidative stress and glutaminolysis , 2021, bioRxiv.

[8]  R. Deberardinis,et al.  Differential requirements for mitochondrial electron transport chain components in the adult murine liver , 2021, bioRxiv.

[9]  B. Faubert,et al.  Isotope tracing reveals glycolysis and oxidative metabolism in childhood tumors of multiple histologies. , 2021, Med.

[10]  M. V. Heiden,et al.  Cell Programmed Nutrient Partitioning in the Tumor Microenvironment , 2020, bioRxiv.

[11]  S. Weinberg,et al.  Mitochondrial ubiquinol oxidation is necessary for tumor growth , 2020, Nature.

[12]  Jason W. Locasale,et al.  Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing , 2020, Nature Cell Biology.

[13]  Gary D Bader,et al.  Relapse fated latent diagnosis subclones in acute B lineage leukaemia are drug tolerant and possess distinct metabolic programs. , 2020, Cancer discovery.

[14]  Steven L Salzberg,et al.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.

[15]  P. A. Futreal,et al.  Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases. , 2019, Cancer discovery.

[16]  J. Massagué,et al.  Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization , 2019, eLife.

[17]  B. Faubert,et al.  Metabolic diversity in human non-small cell lung cancer , 2014, bioRxiv.

[18]  R. Deberardinis,et al.  Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo. , 2018, Cell metabolism.

[19]  M. V. Vander Heiden,et al.  Aspartate is an endogenous metabolic limitation for tumour growth , 2018, Nature Cell Biology.

[20]  R. Gibbs,et al.  The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. , 2018, Cell reports.

[21]  M. Snuderl,et al.  Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumors , 2018, Nature Cell Biology.

[22]  King-Jen Chang,et al.  Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway. , 2018, Cancer research.

[23]  R. Deberardinis,et al.  The abundance of metabolites related to protein methylation correlates with the metastatic capacity of human melanoma xenografts , 2017, Science Advances.

[24]  Jamey D. Young,et al.  Lactate Metabolism in Human Lung Tumors , 2017, Cell.

[25]  M. Carroll,et al.  Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. , 2017, Cancer discovery.

[26]  Xin Gao,et al.  Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase , 2017, Cell.

[27]  C. Sander,et al.  Mitochondrial respiratory gene expression is suppressed in many cancers , 2016, eLife.

[28]  Joerg M. Buescher,et al.  Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis. , 2016, Cell reports.

[29]  Christian M. Metallo,et al.  Reductive carboxylation supports redox homeostasis during anchorage-independent growth , 2016, Nature.

[30]  B. Faubert,et al.  Metabolic Heterogeneity in Human Lung Tumors , 2016, Cell.

[31]  Chris Sander,et al.  An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. , 2016, Cancer cell.

[32]  Abstr Act,et al.  Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma , 2016 .

[33]  Chang S. Chan,et al.  The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis , 2015, Cell reports.

[34]  R. Deberardinis,et al.  Oxidative stress inhibits distant metastasis by human melanoma cells , 2015, Nature.

[35]  Robert A. Egnatchik,et al.  Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells , 2015, Cancer & metabolism.

[36]  Martin L. Miller,et al.  Mitochondrial DNA copy number variation across human cancers , 2015, bioRxiv.

[37]  D. Lindgren,et al.  Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate , 2015, Cell Death and Disease.

[38]  M. Amin,et al.  Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma , 2015, Modern Pathology.

[39]  John M. Asara,et al.  Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function , 2014, Nature.

[40]  Lawrence A. Donehower,et al.  The somatic genomic landscape of chromophobe renal cell carcinoma. , 2014, Cancer cell.

[41]  R. Shader.  Phase I trials. , 2014, Clinical Therapeutics.

[42]  D. Sabatini,et al.  Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides , 2014, Nature.

[43]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[44]  T. Yagi,et al.  Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. , 2013, The Journal of clinical investigation.

[45]  R. Deberardinis,et al.  Metabolism of [U‐13C]glucose in human brain tumors in vivo , 2012, NMR in biomedicine.

[46]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[47]  W. Marston Linehan,et al.  Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.

[48]  M. Brand,et al.  High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated Mitochondria , 2011, PloS one.

[49]  R. Deberardinis,et al.  Pyruvate carboxylase is required for glutamine-independent growth of tumor cells , 2011, Proceedings of the National Academy of Sciences.

[50]  M. Brand,et al.  Assessing mitochondrial dysfunction in cells , 2011, The Biochemical journal.

[51]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[52]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[53]  Hanna Y. Irie,et al.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.

[54]  D. Meierhofer,et al.  Loss of Complex I due to Mitochondrial DNA Mutations in Renal Oncocytoma , 2008, Clinical Cancer Research.

[55]  E. Bonora,et al.  Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. , 2008, Human molecular genetics.

[56]  S. Burgess,et al.  NMR indirect detection of glutamate to measure citric acid cycle flux in the isolated perfused mouse heart , 2001, FEBS letters.

[57]  W. Kaelin,et al.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[58]  A. Sherry,et al.  Carbon flux through citric acid cycle pathways in perfused heart by 13C NMR spectroscopy , 1987, FEBS letters.